Loading . . .

A Breath of Life

Monash Institute of Pharmaceutical Sciences is working to develop an inhaled oxytocin treatment for PPH, excessive bleeding after childbirth that kills an estimated 140,000 women a year.

Helping Translate Academic Research into New Therapeutics

The European ScreeningPort (ESP) enables academic researchers with promising data on the causes of disease to get physiologically relevant results and help support translating them into potential new therapeutics.

Featured Products

IVIS SpectrumCT Preclinical In Vivo Imaging System

IVIS Spectrum In Vivo Imaging System

The IVIS® Spectrum in vivo imaging system uses a novel patented optical imaging technology to facilitate non-invasive longitudinal monitoring of disease progression, cell trafficking and gene expression patterns in living animals.

EnSight Multimode Plate Reader

EnSight™ Multimode Plate Reader

The EnSight Multimode Plate Reader is the first benchtop system to offer well-imaging alongside label-free and labeled detection technologies.

Alpha Reagents

Alpha Technology

Our Alpha technology provides a unique beads-based platform that combines convenience, optimal performance, and superior flexibility.

Drug Discovery And Development

Monitoring the progression of disease is paramount to understanding better drug design, safety, and efficacy.

Our solutions focused on target discovery, hit-to-lead optimization, as well as assay development and screening let scientists better determine the viability of a target candidate earlier in the process. Through innovative in vivo and in vitro approaches to target discovery, screening, lead optimization, and pre-clinical testing solutions scientists are enabled to make better decisions throughout the research cycle, resulting in more cost-effective, efficient, and predictive drug discovery and development.